Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 119,427 |
|
|||||
| News | - | ||||||
| Day High | 0.7068 | Low High |
|||||
| Day Low | 0.6532 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Galecto Inc | GLTO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0359 | 5.37% | 0.7048 | 17:17:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.677 | 0.6532 | 0.7068 | 0.7048 | 0.6689 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 262 | 119,427 | $ 0.6830871 | $ 81,579 | - | 0.50 - 3.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:40:46 | 30 | $ 0.7064 | USD |
Galecto Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 18.98M | 27.11M | - | 0 | -38.35M | -1.41 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galecto News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLTO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.711 | 0.719899 | 0.65 | 0.6840603 | 69,399 | -0.0062 | -0.87% |
| 1 Month | 0.80 | 0.80995 | 0.60 | 0.7123127 | 126,033 | -0.0952 | -11.90% |
| 3 Months | 0.62 | 0.94 | 0.5612 | 0.7500948 | 217,474 | 0.0848 | 13.68% |
| 6 Months | 0.5654 | 0.94 | 0.50 | 0.6822282 | 285,276 | 0.1394 | 24.66% |
| 1 Year | 1.90 | 3.70 | 0.50 | 0.9864578 | 364,831 | -1.20 | -62.91% |
| 3 Years | 6.07 | 16.41 | 0.50 | 3.11 | 276,649 | -5.37 | -88.39% |
| 5 Years | 15.77 | 17.99 | 0.50 | 3.28 | 243,727 | -15.07 | -95.53% |
Galecto Description
| Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis. |
